Lymphoma

Top Story

NIH selects five Lasker Clinical Research Scholars

November 16, 2019
FDA News

FDA approves Brukinsa for relapsed or refractory mantle cell lymphoma

November 14, 2019
The FDA granted accelerated approval to zanubrutinib for use by adults with previously treated mantle cell lymphoma. Zanubrutinib (Brukinsa, BeiGene) — an oral…
Meeting NewsPerspective

Novel blood tests could improve cancer detection

November 14, 2019
Two novel blood assays demonstrated efficacy in detecting various cancer types at different disease stages, according to results of two studies presented at ASCO…
In the Journals

Pembrolizumab induces durable responses in relapsed, refractory primary mediastinal large B-cell lymphoma

November 14, 2019
Pembrolizumab appeared to be associated with high response rates, durable activity and manageable toxicity among patients with relapsed or refractory primary mediastinal…
More Headlines »
CME ABIM MOC

Ace the Case: A 65-Year-Old Female With Cough and Shortness of Breath

There is no commercial support for this activity.

Ace the Case: A 65-Year-Old Female With Cough and Shortness of Breath
More »
Video
Meeting News

VIDEO: AstraZeneca executive highlights ‘extensive’ development program for acalabrutinib in CLL

June 25, 2019
More »
Resource Centers